Yale and BI seek applications from postdocs
Yale University and Boehringer Ingelheimare seeking applications for Postdoctoral Researchers for a newly launched Biomedical Data Science Fellowship, which is a three-year full-time program. Applicants...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Yale University and Boehringer Ingelheimare seeking applications for Postdoctoral Researchers for a newly launched Biomedical Data Science Fellowship, which is a three-year full-time program. Applicants...
Cybrexa Therapeutics reports that the first patient has been dosed in a Phase 1/2 clinical trial evaluating CBX-12 (alphalex™-exatecan), the company’s lead therapeutic candidate. The...
Biorez reports that it has received 510(k) clearance from the FDA for two sizes of its BioBrace Implant. This new biocomposite soft tissue scaffold is...
InveniAI® reports the appointment of Salvatore (Salvo) Alesci, M.D., Ph.D., as its Chief Scientific Officer. Dr. Alesci, a physician-scientist, R&D strategist, and science policy influencer...
Southern Connecticut State University has received a grant from the National Science Foundation to increase the number of physics, chemistry, and math teachers in high-needs school...
Taconic Biosciences has launched a new COVID-19 mouse model. This human ACE2 (hACE2) transgenic mouse expands Taconic’s COVID-19 research toolkit. In October 2020, Taconic launched its...
New Haven’s Precipio has begun marketing a new 20-minute COVID-19 antibody test on e-commerce giant Amazon’s business platform. The Science Park-based diagnostics company has a...
MAPS-CT (Mentorship, Advisors, Peers, Sponsorship) provides mentorship in a collaborative learning and nurturing environment for women at various stages of their careers, from all areas...
Developer Alex Twining has big dreams of restoring the Science Parkarea of New Haven to its former glory, making it a place where people will...
The CBIA Bioscience Growth Council has written to Governor Ned Lamont of Connecticut opposing HB 6447. Their letter states: “The Connecticut biopharmaceutical community opposes HB...